Administrative Core
行政核心
基本信息
- 批准号:10628879
- 负责人:
- 金额:$ 20.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvisory CommitteesAgreementAnnual ReportsApplications GrantsAreaBudgetsCancer BiologyCancer CenterCollaborationsCommittee MembersConsultationsCountryDataDecision MakingDevelopmentDisputesEligibility DeterminationEnsureFacultyFee-for-Service PlansFeedbackFeesFlow CytometryFosteringFundingGoalsGrantHistologyImageImmune responseInstitutionJointsLeadLeadershipMalignant NeoplasmsManuscriptsMentorsMissionNorth DakotaPhasePilot ProjectsPrincipal InvestigatorProductivityProgram ReviewsProgress ReportsPublicationsReport (document)ReportingResearchResearch ActivityResearch PersonnelResolutionRoleScientific EvaluationServicesSiteSpecialistStructureSystemUnited States National Institutes of HealthUniversitiesWorkWritinganticancer researchbasecohesionfallsindividual responsibilityinnovationmeetingsmembernerve supplyoperationprogramsresearch facultysuccesstumortumor microenvironmentvirtualvoucherwaiver
项目摘要
Abstract
The Administrative Core (Core A) of the Center for Cancer Biology Research (CCBR) at Sanford Research is
not only essential for all research activities occurring within the CCBR but also for that within Sanford Research
as a whole. The funds requested in Phase III will provide continued support for the Principal Investigator,
Program Coordinator and Project Manager. These key individuals are responsible for the overall administration
of the CCBR. We also propose to fully support the Lead Research Technician and Senior Research Specialist
of the Histology & Imaging Core (Core B) as well as a Manager and Technician in the Flow Cytometry Core
(Core C). We will additionally support a Pilot Grant program to ensure continued funding of innovative research
in the region and use of the CCBR's Scientific Cores. A Steering Committee composed of previous CoBRE
Project Leaders as well as Sanford Research leaders will ensure successful functioning of the Scientific Cores.
An External Advisory Committee, composed of leaders in the Cancer Biology field, will work with external
reviewers from North Dakota State University, the Administrative Core and the Steering Committee to select
Pilot Grant awardees and resolve any issues that may arise within the CCBR or its Scientific Cores. The
Administrative Core will accomplish the following Specific Aims: 1) To support the existing Scientific Cores,
enabling self-sufficiency and 2) To continue a program of Pilot Grants. In order to achieve these goals, the
Administrative Core will meet twice a year (Fall and Spring) with the Steering and External Advisory Committees.
The Spring meeting will serve as a review of the program and evaluation of the Scientific Cores as they work
towards self-sustainability. Importantly, the Administrative Core will prioritize and oversee the allocation of funds
such that they meet institutional strategic needs and are in line with the NIH mission. Moreover, the
Administrative Core will continue to focus on the CCBR's existing areas of cancer research while expanding to
include additional innovative and impactful areas. The CCBR will have the following focus areas: 1) tumor
innervation, 2) tumor immune response, 3) tumor microenvironment and 4) tumor development. The ultimate
goals of the Administrative Core are to continue funding cancer research in the region and to bring the CCBR's
Scientific Cores to self-sufficiency. The plan laid out in this section will ensure success of the CCBR.
摘要
桑福德研究中心癌症生物学研究中心(CCBR)的行政核心(核心A)是
这不仅对CCBR内的所有研究活动至关重要,而且对桑福德研究所内的研究活动也至关重要
作为一个整体。第三阶段申请的资金将继续为主要研究员提供支助,
项目协调员和项目经理。这些关键人物负责全面管理
的CCBR。我们还建议全力支持首席研究技术员和高级研究专家
组织学和成像核心(核心B)以及流式细胞术核心的经理和技术员
(Core C)。此外,我们还将支持一项试点赠款计划,以确保创新研究的持续资助。
以及CCBR科学核心的使用。指导委员会,由前CoBRE成员组成
项目负责人以及桑福德研究领导人将确保科学核心的成功运作。
由癌症生物学领域领导者组成的外部咨询委员会将与外部合作
来自北达科他州州立大学、行政核心和指导委员会的评审员,
试点补助金的授予和解决任何可能出现的问题,在CCBR或其科学核心。的
行政核心将实现以下具体目标:1)支持现有的科学核心,
2)继续试点赠款计划。为了实现这些目标,
行政核心将与指导委员会和外部咨询委员会每年举行两次会议(秋季和春季)。
春季会议将作为对科学核心工作的计划和评估的审查
走向自我可持续性。重要的是,行政核心将优先考虑和监督资金的分配,
以满足机构战略需求并符合NIH的使命。而且
行政核心将继续专注于CCBR现有的癌症研究领域,同时扩大到
包括其他创新和有影响力领域。CCBR将重点关注以下领域:1)肿瘤
神经支配,2)肿瘤免疫应答,3)肿瘤微环境和4)肿瘤发展。最终
行政核心的目标是继续资助该地区的癌症研究,
科学的核心是自给自足。本节中列出的计划将确保CCBR的成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W KEITH MISKIMINS其他文献
W KEITH MISKIMINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W KEITH MISKIMINS', 18)}}的其他基金
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8712424 - 财政年份:2013
- 资助金额:
$ 20.49万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8858397 - 财政年份:2013
- 资助金额:
$ 20.49万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
8590394 - 财政年份:2013
- 资助金额:
$ 20.49万 - 项目类别:
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
(PQA1)糖尿病药物二甲双胍杀死癌细胞的分子机制
- 批准号:
9063480 - 财政年份:2013
- 资助金额:
$ 20.49万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 20.49万 - 项目类别:
Standard Grant